Catalent
CTLT
#1501
Rank
NZ$20.17 B
Marketcap
$111.15
Share price
0.00%
Change (1 day)
20.82%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2023 (TTM): -$2.09

According to Catalent's latest financial reports the company's current EPS (TTM) is -$2.26. In 2022 the company made an earnings per share (EPS) of $3.97 a decrease over its 2021 EPS that were of $5.73.

EPS history for Catalent from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.09-152.63%
2022$3.97-30.58%
2021$5.7379.67%
2020$3.19114.12%
2019$1.49-15%
2018$1.7575.44%
2017$1.00-22.97%
2016$1.30-59.56%
2015$3.20282.05%
2014$0.84-378.2%
2013-$0.30

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$1.38-161.24%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.31-41.86%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.47 9.30%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$11.19-595.35%๐Ÿ‡บ๐Ÿ‡ธ USA